Diagnostics Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
28/10/2025 13:56
Oct 28 (Reuters) - Co-Diagnostics Inc CODX.O: CO-DIAGNOSTICS, INC. ANNOUNCES PRICING OF $7.0 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK PRICED AT-THE-MARKET UNDER NASDAQ RULES CO-DIAGNOSTICS INC - 12,727,272 SHARES OFFERED AT $0.55 PER SHARE Source text: ID:nPn4RFrCva Further company coverage: CODX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Co-Diagnostics
See all newsDiagnostics' Joint Venture Cosara Diagnostics Announces Publication Of Peer-Reviewed Hpv Screening Study Using Cosara's Saragene® Test
Diagnostics - Cosara To Initiate Sales Activities Across India And South Asia
Diagnostics’ Brian Brown Stepped Down As CFO Effective September 2
Diagnostics Q2 revenue rises slightly amid international expansion
Diagnostics - Amends Equity Distribution Agreement With Maxim Group For Common Stock Sale - SEC Filing